Some phenolic natural compounds as carbonic anhydrase inhibitors: An in vitro and in silico study

Arch Pharm (Weinheim). 2022 Jun;355(6):e2100476. doi: 10.1002/ardp.202100476. Epub 2022 Mar 20.

Abstract

This paper presents experimental and molecular docking studies on the inhibitory effects of tyrosol, hydroxytyrosol, luteolin, diosmetin, caffeic acid, luteolin 7-O-glycoside, and apigenin 7-O-glycoside from olive (Olea europaea L.) leaf against human carbonic anhydrase (hCA, E.C.4.2.1.1) isozymes I and II. After these isozymes were separately purified, their activities were determined using the esterase activity. IC50 values for hCA I and II were calculated as 2.02-11.38 µM and 2.23-9.05 µM, respectively. The compounds were identified as CA inhibitors, with Ki values in the ranges of 1.66-9.17 µM for the hCA I isozyme and 1.49-14.21 µM for hCA II. The inhibitory effects of these natural compounds were also compared to acetazolamide, which is a potent inhibitor of both CA isozymes. Our results may contribute to the synthesis of new CA inhibitors and pave the way for new drug design in the treatment of a number of diseases including cancer, obesity, diabetes, and glaucoma.

Keywords: carbonic anhydrase; enzyme inhibition; molecular docking; olive leaf; phenolic compound.

MeSH terms

  • Carbonic Anhydrase I*
  • Carbonic Anhydrase II
  • Carbonic Anhydrase Inhibitors* / pharmacology
  • Glycosides
  • Humans
  • Isoenzymes
  • Luteolin
  • Molecular Docking Simulation
  • Phenols / pharmacology
  • Structure-Activity Relationship

Substances

  • Carbonic Anhydrase Inhibitors
  • Glycosides
  • Isoenzymes
  • Phenols
  • Carbonic Anhydrase I
  • Carbonic Anhydrase II
  • Luteolin

Grants and funding